09.02.2011 • News

Carbogen Amcis Enhances Stability Studies Capacity

Swiss-based Carbogen Amcis, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonization (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

Carbogen Amcis' new fully validated and mapped stability chambers operate at ICH conditions (25°C/60% RH, 30°C/65% RH, and 40°C/75% RH) and at low temperatures (5°C, -20°C and -80°C). With a current shelf storage capacity of about 92 m2, they provide secure and safe storage for API  samples, including highly potent material, employed for in-house stability studies.

"We are facing an increasing customer demand for stability studies, as a stand-alone service or tied to our API development and production efforts," Brian O'Neill, Carbogen Amcis sales manager, said.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read